logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

DAWNRAYS PHARMA (02348) repurchased 236,000 shares on October 23 for HK$223,200.

date
18:00 23/10/2026
avatar
GMT Eight
DAWNRAYS PHARMA (02348) announced that on October 23, 2026, it spent HK$223,200 to repurchase 236,000 shares.
DAWNRAYS PHARMA (02348) announced that on October 23, 2026, it spent HK$223,200 to repurchase 236,000 shares.
Related Articles
HK Stock
FS.COM (03355) Reports Adjusted Net Profit of RMB 778 Million for the First Three Quarters, Up 68.9% Year-on-Year
HK Stock
SIMCERE PHARMA (02096) repurchased 339,000 shares on October 23 for approximately HK$3.6324 million.
HK Stock
PW MEDTECH (01358) repurchased 2.409 million shares on October 23 for HK$2.1669 million.
FS.COM (03355) Reports Adjusted Net Profit of RMB 778 Million for the First Three Quarters, Up 68.9% Year-on-Year
HK Stock
SIMCERE PHARMA (02096) repurchased 339,000 shares on October 23 for approximately HK$3.6324 million.
HK Stock
PW MEDTECH (01358) repurchased 2.409 million shares on October 23 for HK$2.1669 million.
HK Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.